527 related articles for article (PubMed ID: 28769795)
1. Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis.
Walton KL; Johnson KE; Harrison CA
Front Pharmacol; 2017; 8():461. PubMed ID: 28769795
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.
Verrecchia F; Mauviel A
J Invest Dermatol; 2002 Feb; 118(2):211-5. PubMed ID: 11841535
[TBL] [Abstract][Full Text] [Related]
3. Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-β signaling.
Kanaoka M; Yamaguchi Y; Komitsu N; Feghali-Bostwick CA; Ogawa M; Arima K; Izuhara K; Aihara M
J Dermatol Sci; 2018 May; 90(2):199-208. PubMed ID: 29433908
[TBL] [Abstract][Full Text] [Related]
4. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
5. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.
Morales MG; Vazquez Y; Acuña MJ; Rivera JC; Simon F; Salas JD; Alvarez Ruf J; Brandan E; Cabello-Verrugio C
Int J Biochem Cell Biol; 2012 Nov; 44(11):1993-2002. PubMed ID: 22964022
[TBL] [Abstract][Full Text] [Related]
7. New insights into TGF-β/Smad signaling in tissue fibrosis.
Hu HH; Chen DQ; Wang YN; Feng YL; Cao G; Vaziri ND; Zhao YY
Chem Biol Interact; 2018 Aug; 292():76-83. PubMed ID: 30017632
[TBL] [Abstract][Full Text] [Related]
8. 15-Deoxy-Δ-12, 14-prostaglandin J2 acts cooperatively with prednisolone to reduce TGF-β-induced pro-fibrotic pathways in human osteoarthritis fibroblasts.
Vaamonde-Garcia C; Malaise O; Charlier E; Deroyer C; Neuville S; Gillet P; Kurth W; Meijide-Failde R; Malaise MG; de Seny D
Biochem Pharmacol; 2019 Jul; 165():66-78. PubMed ID: 30936016
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.
Painemal P; Acuña MJ; Riquelme C; Brandan E; Cabello-Verrugio C
Biofactors; 2013; 39(4):467-75. PubMed ID: 23460581
[TBL] [Abstract][Full Text] [Related]
10. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.
Xu F; Liu C; Zhou D; Zhang L
J Histochem Cytochem; 2016 Mar; 64(3):157-67. PubMed ID: 26747705
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
[TBL] [Abstract][Full Text] [Related]
12. TGF-β/Smad and Renal Fibrosis.
Ma TT; Meng XM
Adv Exp Med Biol; 2019; 1165():347-364. PubMed ID: 31399973
[TBL] [Abstract][Full Text] [Related]
13. Melittin inhibits TGF-β-induced pro-fibrotic gene expression through the suppression of the TGFβRII-Smad, ERK1/2 and JNK-mediated signaling pathway.
Park SH; Cho HJ; Jeong YJ; Shin JM; Kang JH; Park KK; Choe JY; Park YY; Bae YS; Han SM; Moon SK; Kim WJ; Choi YH; Chang YC
Am J Chin Med; 2014; 42(5):1139-52. PubMed ID: 25178280
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.
Rodríguez-Vita J; Sánchez-López E; Esteban V; Rupérez M; Egido J; Ruiz-Ortega M
Circulation; 2005 May; 111(19):2509-17. PubMed ID: 15883213
[TBL] [Abstract][Full Text] [Related]
15. ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts.
Muñoz-Félix JM; Perretta-Tejedor N; Eleno N; López-Novoa JM; Martínez-Salgado C
Biochim Biophys Acta; 2014 Jun; 1843(6):1111-22. PubMed ID: 24594380
[TBL] [Abstract][Full Text] [Related]
16. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring.
Cutroneo KR
Wound Repair Regen; 2007; 15 Suppl 1():S54-60. PubMed ID: 17727468
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta signaling in vascular fibrosis.
Ruiz-Ortega M; Rodríguez-Vita J; Sanchez-Lopez E; Carvajal G; Egido J
Cardiovasc Res; 2007 May; 74(2):196-206. PubMed ID: 17376414
[TBL] [Abstract][Full Text] [Related]
19. Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β-ERK5 Interaction.
Kadoya K; Togo S; Tulafu M; Namba Y; Iwai M; Watanabe J; Okabe T; Jin J; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Takeda T; Kondo N; Takahashi K
Cell Physiol Biochem; 2019; 52(4):822-837. PubMed ID: 30946557
[TBL] [Abstract][Full Text] [Related]
20. The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma.
Ihn H
Arch Immunol Ther Exp (Warsz); 2002; 50(5):325-31. PubMed ID: 12455866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
